Healthcare companies routinely review which pharmacy stores to target.

Stores are segmented by sales potential, banner, location, historical performance, strategic importance and growth opportunity. Call frequencies are adjusted, territories are redesigned and field resources are directed towards the stores where they are expected to create the greatest value.

This work is necessary and, in many organisations, increasingly sophisticated.

But there is another question that may not receive the same level of scrutiny: once the stores have been segmented, is the way each segment is serviced and engaged still the right one?

Targeting answers who. It does not fully answer how.

Segmentation helps a business decide which stores warrant attention and how frequently they should be visited. But it does not necessarily determine what kind of engagement each store needs.

One store may require a strategic discussion with the owner. Another may need a clinical conversation with the pharmacist. A third may need the retail manager to understand the product and its place within the category.

These are three different stakeholders, often working different hours and carrying different priorities.

A representative may visit the store and have an excellent conversation—but meet only one of them. The remaining stakeholders may not be available, and the next scheduled visit may be six weeks away.

The targeting was correct. The field interaction was valuable. But the engagement remains incomplete.

Companies regularly review which stores to prioritise. How often do they review what happens inside those stores between visits?

Field teams are important—and their impact should travel further

Field teams remain central to pharmacy engagement. They build relationships, understand local circumstances and manage conversations that depend on trust, influence and commercial judgement.

Their importance should be acknowledged clearly. This is not about replacing representatives or reducing their role. It is about multiplying their impact.

A representative can create the initial momentum: introducing the brand, establishing its relevance and securing commitment from a key stakeholder. But the brand's presence within the store should not disappear when the representative walks out.

The opportunity is to create an engagement model in which the field visit becomes the beginning of a wider sequence, rather than a standalone event.

The pharmacist who was unavailable should still encounter the clinical proposition. The retail manager should still understand what needs to happen on the shelf. The wider pharmacy team should still know how to identify an appropriate customer or make a recommendation.

The brand should continue to echo through the store long after the visit is complete—and throughout the six weeks before the representative returns.

Multiply rep impact. Execute where they cannot.

Representatives cannot be in every store, meet every stakeholder or follow up every incomplete action. This is not a limitation of the field team. It is the practical reality of geography, time, store access and competing priorities.

A complementary engagement layer can extend the representative's work without trying to replicate it.

Structured digital pharmacy activities can reinforce the message and give different team members access to the information when they are available. Phone-based engagement can reach the stakeholder who was absent, answer practical questions and prompt the next action. Follow-up can continue until the store has moved from initial interest to meaningful participation.

This allows the representative's message to travel beyond the person they met on the day.

It also enables engagement in stores that may be commercially relevant but cannot receive regular field coverage. These stores do not necessarily need to remain untouched simply because an in-person visit is impractical.

The objective is straightforward: multiply rep impact in the stores they visit and execute where they cannot.

Field, digital and phone channels converging on a single store, keeping the brand present between visits.

Coverage is not the same as completed engagement

Coverage is frequently described through the number of stores called on, visit frequency or the proportion of a target list reached. These measures are important, but they mainly describe field activity.

They do not always show whether the brand became embedded within the store.

A store may have been visited without the pharmacist being present. The campaign may have been discussed with the owner but not communicated to the wider team. An action may have been agreed but remain incomplete. A product may have been ranged centrally but still be absent from the shelf.

The distinction matters because pharmacy campaigns increasingly depend on more than delivering a message. They require the store to do something.

That might involve completing education, confirming stock, uploading a photograph, positioning material, identifying suitable customers or delivering a professional service.

A modern engagement model should therefore be evaluated not only by whether the store was reached, but by whether the relevant people were engaged and the intended activity occurred.

The cost framework matters—but this is not simply cost-cutting

The economics of store coverage cannot be ignored. Representative capacity, travel, territory size, visit frequency and cost per call are legitimate commercial considerations.

A blended model can create a substantial cost benefit, particularly when it extends engagement into geographically dispersed or lower-frequency stores. But reducing cost is not the central idea.

The larger opportunity is to create a different quality and continuity of engagement.

A lower-cost interaction that produces no meaningful response has limited value. Equally, using a highly valuable field visit for routine follow-up may not be the best use of the representative's time.

The more useful question is not simply, “How can we service stores for less?”

It is: how can we use each channel for the work it performs best—and create more engagement from the total investment?

Field teams can focus on relationships, influence, negotiation and complex conversations. Digital workflows can provide consistency and make the required store activity clear. Campaign Coordinators can reach missing stakeholders, answer questions and maintain momentum between visits.

Cost efficiency is an important consequence. Greater engagement is the primary opportunity.

What a segment-led service model could look like

A more deliberate model would connect each store segment with an engagement pathway suited to the desired outcome.

Strategic stores may continue to receive high-touch field engagement, reinforced by digital activities and structured follow-up. Growth stores may benefit from selective visits combined with phone and digital support. Wider-network stores may be engaged through scalable digital and phone-based channels, with field involvement introduced when the opportunity or complexity justifies it.

This is not about moving stores away from representatives. It is about surrounding field activity with an engagement system that helps the message persist, reach more people and produce measurable action.

It moves the coverage conversation beyond a binary distinction between stores that are visited and stores that are not.

A store can be meaningfully engaged even when a representative cannot be physically present. And when a representative does visit, the value of that interaction can continue well beyond the time spent in the store.

When did you last review the model itself?

Most healthcare companies can explain how their pharmacy universe is segmented, which stores are prioritised and how frequently they should be visited.

The harder question is whether the model used to engage those stores has been reviewed with the same discipline.

The existing model may not be failing. It may be operating exactly as designed. But store pressures, stakeholder availability, engagement channels and campaign requirements have changed.

The next coverage review may therefore need to go beyond asking: which stores should we target?

It may also need to ask: how do we multiply the impact of every representative interaction, keep our brand present between visits and execute in the stores our field teams cannot reach?